Basilea Pharmaceutica Ltd. (United States)

Basilea Pharmaceutica is a Swiss biopharmaceutical company focused on developing anti-infective and oncology treatments. The company created Cresemba (isavuconazole), a broad-spectrum antifungal for invasive aspergillosis and mucormycosis, and Zevtera (ceftobiprole) for hospital-acquired bacterial pneumonia. Basilea addresses critical unmet needs in serious fungal and bacterial infections resistant to standard treatments.